| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Roger S McIntyre | Q88039086 |
| P2093 | author name string | Ha T Nguyen | |
| Hanna O Woldeyohannes | |||
| Jakub Z Konarski | |||
| Joanna K Soczynska | |||
| Maria Teresa C Lourenco | |||
| P2860 | cites work | The prevalence and impact of migraine headache in bipolar disorder: results from the Canadian Community Health Survey. | Q51916839 |
| General-medical conditions in older patients with serious mental illness. | Q51932811 | ||
| Is migraine in unipolar depressed patients a bipolar spectrum trait? | Q51933196 | ||
| Increased risk for pulmonary embolism in patients with bipolar disorder. | Q51933999 | ||
| Suicide attempts and ideation in patients with bipolar I disorder. | Q51941123 | ||
| Prevalence, Clinical Correlates, and Treatment of Migraine in Bipolar Disorder | Q51946593 | ||
| Age at onset in geriatric bipolar disorder. Effects on clinical presentation and treatment outcomes in an inpatient sample. | Q51987833 | ||
| Mesolimbic dopaminergic system activity as a function of food reward: a microdialysis study. | Q52203595 | ||
| The neuroscience of addiction. | Q52288386 | ||
| Prevalence of migraine in bipolar disorder | Q59706991 | ||
| Correlates of overweight and obesity in 644 patients with bipolar disorder | Q60646356 | ||
| Differences and similarities in mixed and pure mania | Q71993596 | ||
| Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS | Q72289439 | ||
| Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis | Q72614848 | ||
| Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence | Q72635469 | ||
| Comorbidity of migraine and major affective disorders | Q72829495 | ||
| Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal | Q73029501 | ||
| Evaluation of thyroid function in lithium-naive bipolar patients | Q73206118 | ||
| Prevalence of overweight and obesity in bipolar patients | Q73805994 | ||
| Body mass index in persons with schizophrenia | Q74436217 | ||
| The prevalence of migraine in patients with bipolar and unipolar affective disorders | Q77790930 | ||
| Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania | Q79470954 | ||
| Increased risk of hypertension in patients with bipolar disorder and patients with anxiety compared to background population and patients with schizophrenia | Q79731969 | ||
| Psychiatric comorbidity in older adults with bipolar disorder | Q79750754 | ||
| Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization | Q80000044 | ||
| A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic | Q80836021 | ||
| Medical comorbidity in a bipolar outpatient clinical population | Q80985306 | ||
| Overweight and obesity in bipolar disorders | Q82729258 | ||
| Practice guideline for the treatment of patients with bipolar disorder (revision) | Q95789383 | ||
| Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls | Q24550675 | ||
| Cytokines sing the blues: inflammation and the pathogenesis of depression | Q24633065 | ||
| Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review | Q28272260 | ||
| Central nervous system control of food intake | Q29547439 | ||
| The neural basis of addiction: a pathology of motivation and choice | Q29615901 | ||
| Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle | Q30662478 | ||
| Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). | Q30977443 | ||
| Prevalence and clinical correlates of medical comorbidities in patients with bipolar I disorder: analysis of acute-phase data from a randomized controlled trial | Q31048788 | ||
| Brain dopamine and obesity | Q32040881 | ||
| The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection | Q33731311 | ||
| Mood disorders in multiple sclerosis: diagnosis and treatment. | Q33953129 | ||
| Excess mortality in bipolar and unipolar disorder in Sweden | Q33954560 | ||
| Substance abuse in bipolar disorder | Q34365967 | ||
| Mechanisms of antipsychotic-induced weight gain | Q34403433 | ||
| The treatment of unrelated disorders in patients with chronic medical diseases | Q34468642 | ||
| Management of comorbid bipolar disorder and substance abuse. | Q34564694 | ||
| Mood disorders in patients with epilepsy: epidemiology and management | Q34626893 | ||
| Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. | Q34735182 | ||
| Studies of hormone action in the hippocampal formation: possible relevance to depression and diabetes | Q34959897 | ||
| An evidence-based review of psychosocial treatments for bipolar disorder. | Q34979410 | ||
| Cytokines and cognition--the case for a head-to-toe inflammatory paradigm | Q35020920 | ||
| Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment | Q35189666 | ||
| Alcoholism and obesity: overlapping neuropeptide pathways? | Q35617839 | ||
| Insulin and neurodegenerative disease: shared and specific mechanisms | Q35674377 | ||
| Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels. | Q35749653 | ||
| Convergences in course of illness and treatments of the epilepsies and recurrent affective disorders | Q35757918 | ||
| Are mood disorders and obesity related? A review for the mental health professional. | Q35783981 | ||
| Comorbidity in bipolar disorder: a framework for rational treatment selection | Q35859860 | ||
| Association between obesity and psychiatric disorders in the US adult population | Q35880425 | ||
| Cytokines and psychopathology: lessons from interferon-alpha | Q35970243 | ||
| Psychiatric and medical comorbidities of bipolar disorder | Q36021272 | ||
| Medical comorbidity and health-related quality of life in bipolar disorder across the adult age span. | Q36093549 | ||
| Executive dysfunction in major depressive disorder | Q36106773 | ||
| How can drug addiction help us understand obesity? | Q36108706 | ||
| Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies | Q36161335 | ||
| The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. | Q36192638 | ||
| Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications | Q36216515 | ||
| Schizophrenia and increased risks of cardiovascular disease | Q36336286 | ||
| Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities | Q36521858 | ||
| Medical comorbidity in bipolar disorder: re-prioritizing unmet needs | Q36841349 | ||
| Neurocognition in depression: patients on and off medication versus healthy comparison subjects | Q38406779 | ||
| Patterns of memory impairment in bipolar disorder and unipolar major depression | Q38407570 | ||
| Primary mania versus HIV-related secondary mania in Uganda | Q38879225 | ||
| Brain neurotransmitters in food and drug reward | Q39403073 | ||
| The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment | Q40850649 | ||
| The dexamethasone suppression test in patients with mood disorders. | Q41203480 | ||
| Immobilization Stress May Increase Plasma lnterleukin-6 via Central and Peripheral Catecholamines | Q41433952 | ||
| Vagotomy blocks the induction of interleukin-1beta (IL-1beta) mRNA in the brain of rats in response to systemic IL-1beta. | Q41712834 | ||
| Insulin receptors and insulin action in dissociated brain cells | Q43560612 | ||
| Leptin: a modulator of alcohol craving? | Q43593941 | ||
| The association between childhood depression and adulthood body mass index | Q43594544 | ||
| Cytokine-associated emotional and cognitive disturbances in humans | Q43601371 | ||
| Prevalence of obesity and weight change during treatment in patients with bipolar I disorder | Q43642752 | ||
| Determinants of overweight and obesity in patients with bipolar disorder. | Q43683014 | ||
| Substance abuse in first-episode bipolar I disorder: indications for early intervention | Q43702427 | ||
| Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function | Q43843051 | ||
| Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder | Q43947453 | ||
| Obesity as a correlate of outcome in patients with bipolar I disorder | Q44265285 | ||
| Thyroid function in mixed and pure manic episodes | Q44272765 | ||
| Screening for bipolar disorder in the community | Q44318544 | ||
| Brain dopamine is associated with eating behaviors in humans | Q44343333 | ||
| Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions | Q44634738 | ||
| Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors | Q44773988 | ||
| Exposure to appetitive food stimuli markedly activates the human brain | Q44819138 | ||
| Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey | Q44986547 | ||
| Burden of general medical conditions among individuals with bipolar disorder | Q45070754 | ||
| Leptin is associated with craving in females with alcoholism | Q45129191 | ||
| Effects of co-occurring alcohol abuse on the course of bipolar disorder following a first hospitalization for mania | Q46630225 | ||
| Impairment of executive function but not memory in first-degree relatives of patients with bipolar I disorder and in euthymic patients with unipolar depression | Q46683588 | ||
| Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians | Q46714706 | ||
| Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder | Q46756223 | ||
| Brain activation measured with fMRI during a mental arithmetic task in schizophrenia and major depression | Q47228929 | ||
| Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. | Q47408299 | ||
| Clinical features of bipolar disorder with and without comorbid diabetes mellitus | Q47629610 | ||
| Rapid switching of mood in families with multiple cases of bipolar disorder | Q47636882 | ||
| Impact of bipolar disorder on a U.S. community sample. | Q47951026 | ||
| Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients | Q48114087 | ||
| Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis | Q48131514 | ||
| Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers | Q48279855 | ||
| Neurocognitive impairment in drug-free patients with major depressive disorder | Q48377352 | ||
| Inhibitory action of insulin on suprachiasmatic nucleus neurons in rat hypothalamic slice preparations | Q48406887 | ||
| Mania compared with unipolar depression in old age. | Q48519162 | ||
| Neuropsychological function in nonpsychotic unipolar major depression | Q48702663 | ||
| A retrospective case-note study of bipolar disorder in old age. | Q48743596 | ||
| Short-term action of insulin onAplysia neurons: Generation of a possible novel modulator of ion channels | Q48822683 | ||
| Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. | Q48882710 | ||
| Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. | Q50475369 | ||
| Cognitive generation of affect in bipolar depression: an fMRI study. | Q51007669 | ||
| Cognitive deficits are associated with functional impairment in severely depressed patients. | Q51012986 | ||
| DIABETIC ENCEPHALOPATHY. DIFFUSE AND FOCAL LESIONS OF THE BRAIN IN LONG-TERM DIABETES | Q51289858 | ||
| The prevalence of metabolic syndrome in patients with bipolar disorder. | Q51467623 | ||
| Obesity in bipolar disorder and major depressive disorder: results from a national community health survey on mental health and well-being. | Q51785668 | ||
| Substance use disorders and overweight/obesity in bipolar I disorder: preliminary evidence for competing addictions. | Q51898608 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P433 | issue | 2 | |
| P921 | main subject | bipolar disorder | Q131755 |
| psychological stress | Q3500368 | ||
| substance-related disorder | Q4134457 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 203-213 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Dialogues in Clinical Neuroscience | Q24255736 |
| P1476 | title | Medical and substance-related comorbidity in bipolar disorder: translational research and treatment opportunities | |
| P478 | volume | 10 |
| Q27023851 | Allostasis as a conceptual framework linking bipolar disorder and addiction |
| Q30376057 | Co-morditities of environmental diseases: A common cause. |
| Q46519736 | Glutamatergic and HPA-axis pathway genes in bipolar disorder comorbid with alcohol- and substance use disorders. |
| Q34047592 | Metabolic syndrome and childhood trauma: Also comorbidity and complication in mood disorder |
| Q33526671 | Modeling complex genetic and environmental influences on comorbid bipolar disorder with tobacco use disorder. |
| Q36641286 | The diagnosis and treatment of bipolar disorder: recommendations from the current s3 guideline |
Search more.